Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum
Open Access
- 2 August 2008
- journal article
- research article
- Published by Springer Nature in Malaria Journal
- Vol. 7 (1), 148
- https://doi.org/10.1186/1475-2875-7-148
Abstract
Multidrug resistance has emerged to both Plasmodium vivax and Plasmodium falciparum and yet the comparative epidemiology of these infections is poorly defined.This publication has 22 references indexed in Scilit:
- Multidrug-Resistant Plasmodium vivax Associated with Severe and Fatal Malaria: A Prospective Study in Papua, IndonesiaPLoS Medicine, 2008
- Neglect of Plasmodium vivax malariaTrends in Parasitology, 2007
- Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine–pyrimethamine in southern Papua, IndonesiaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2007
- Stronger host response per parasitized erythrocyte in Plasmodium vivax or ovale than in Plasmodium falciparum malariaTropical Medicine & International Health, 2006
- The global distribution of clinical episodes of Plasmodium falciparum malariaNature, 2005
- Chloroquine Resistance inPlasmodium vivaxAntimicrobial Agents and Chemotherapy, 2004
- The interaction between Plasmodium falciparum and P. vivax in children on Espiritu Santo island, VanuatuTransactions of the Royal Society of Tropical Medicine and Hygiene, 1996
- The epidemiology of malaria in a Karen population on the western border of ThailandTransactions of the Royal Society of Tropical Medicine and Hygiene, 1996
- Development of resistance to chloroquine by Plasmodium vivax in MyanmarTransactions of the Royal Society of Tropical Medicine and Hygiene, 1995
- PLASMODIUM VIVAX RESISTANCE TO CHLOROQUINE?The Lancet, 1989